In Vitro Maturation (IVM) for Polycystic Ovary Syndrome (PCOS)
This pilot study will be a prospective investigation to study the efficacy and safety of In-Vitro Maturation (IVM) for women with Polycystic Ovarian Syndrome (PCOS). There will be 10 subjects total in this Study. There will be no blinding to treatment.

In-Vitro Maturation will provide a viable, safe option for women with PCOS attempting pregnancy through the use of Assisted Reproductive Technology (ART).
Polycystic Ovarian Syndrome
OTHER: IVM
Incidence of Biochemical Pregnancy (defined as a rising Beta-HCG level)., 6 months
number of immature oocytes retrieved, 6 months|rates of maturation and fertilization, 6 months|Incidence of Ovarian Hyperstimulation Syndrome (OHSS), 6 months|live births, 1 1/2 years
This pilot study will be a prospective investigation to study the efficacy and safety of In-Vitro Maturation (IVM) for women with Polycystic Ovarian Syndrome (PCOS). There will be 10 subjects total in this Study. There will be no blinding to treatment.

In-Vitro Maturation will provide a viable, safe option for women with PCOS attempting pregnancy through the use of Assisted Reproductive Technology (ART).